This was particularly evident for NSCLC patients, a subgroup of which also showed lower SUV39H1 protein levels in cancer samples with relatively higher TRIP12 that was associated with a favorable prognosis. The gene discussed is SUV39H1; the disease is non-small cell lung carcinoma.